J&J's investment signals pharma's swelling interest in the digital health space — and we expect to see healthcare incumbents become more active investors in telehealth. →
Even in more stable times, clarity was rare enough for healthcare leaders. Now it may be even harder to come by—and therefore, all the more important. →